Literature DB >> 15905727

Intermittent low-level viremia in very early primary HIV-1 infection.

Eberhard W Fiebig1, Charles M Heldebrant, Richard I F Smith, Andrew J Conrad, Eric L Delwart, Michael P Busch.   

Abstract

Serial samples from source plasma donors with confirmed new HIV infection were investigated for low-level viremia (LLV) (ie, < 100 genome copies [cp]/mL) at time points preceding the period of steadily rising viremia above 100 cp/mL (ramp-up viremia). Fifteen of 44 plasma donor panels previously studied for the dynamics of HIV viremia during primary infection contained 70 samples with undetectable HIV-1 RNA by quantitative polymerase chain reaction (PCR). On retesting with a sensitive qualitative reverse transcriptase PCR assay (95% detection at 4 cp/mL), we identified LLV in 13 of 15 panels and 23 of 69 retested samples. In 6 panels, a total of 11 samples (1-3 per panel) were consistent with LLV before ramp-up viremia. These samples preceded the first sample with >100 cp/mL HIV by 9 to 25 days (median = 18 days) and were separated from the latter by at least 1 sample with undetectable viremia by the qualitative PCR assay. We conclude that LLV is not uncommon during the very early period of primary HIV infection preceding ramp-up viremia. It is not known if blood is infectious during this period; however, given the low viral concentrations and transient nature of the observed viremic "blips," the risk of infectivity can be assumed to be small.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905727

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  19 in total

1.  Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.

Authors:  Nicole L Yates; Judith T Lucas; Tracy L Nolen; Nathan A Vandergrift; Kelly A Soderberg; Kelly E Seaton; Thomas N Denny; Barton F Haynes; Myron S Cohen; Georgia D Tomaras
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

2.  SPMM: estimating infection duration of multivariant HIV-1 infections.

Authors:  Tanzy M T Love; Sung Yong Park; Elena E Giorgi; Wendy J Mack; Alan S Perelson; Ha Youn Lee
Journal:  Bioinformatics       Date:  2015-12-31       Impact factor: 6.937

3.  Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequences.

Authors:  Tanzy M T Love; Sally W Thurston; Michael C Keefer; Stephen Dewhurst; Ha Youn Lee
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

4.  Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection.

Authors:  Ruy M Ribeiro; Li Qin; Leslie L Chavez; Dongfeng Li; Steven G Self; Alan S Perelson
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

Review 5.  Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.

Authors:  Jeanne M Lusher; Inge Scharrer
Journal:  Int J Hematol       Date:  2009-11-03       Impact factor: 2.490

6.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Authors:  Michael K P Liu; Natalie Hawkins; Adam J Ritchie; Vitaly V Ganusov; Victoria Whale; Simon Brackenridge; Hui Li; Jeffrey W Pavlicek; Fangping Cai; Melissa Rose-Abrahams; Florette Treurnicht; Peter Hraber; Catherine Riou; Clive Gray; Guido Ferrari; Rachel Tanner; Li-Hua Ping; Jeffrey A Anderson; Ronald Swanstrom; Myron Cohen; Salim S Abdool Karim; Barton Haynes; Persephone Borrow; Alan S Perelson; George M Shaw; Beatrice H Hahn; Carolyn Williamson; Bette T Korber; Feng Gao; Steve Self; Andrew McMichael; Nilu Goonetilleke
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

Review 7.  Modeling sequence evolution in acute HIV-1 infection.

Authors:  Ha Youn Lee; Elena E Giorgi; Brandon F Keele; Brian Gaschen; Gayathri S Athreya; Jesus F Salazar-Gonzalez; Kimmy T Pham; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Beatrice H Hahn; George M Shaw; Bette T Korber; Tanmoy Bhattacharya; Alan S Perelson
Journal:  J Theor Biol       Date:  2009-08-04       Impact factor: 2.691

8.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

9.  Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3.

Authors:  Pushpa Jayaraman; Tuofu Zhu; Lynda Misher; Deepika Mohan; LaRene Kuller; Patricia Polacino; Barbra A Richardson; Helle Bielefeldt-Ohmann; David Anderson; Shiu-Lok Hu; Nancy L Haigwood
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection.

Authors:  Zhong-Min Ma; Mars Stone; Mike Piatak; Becky Schweighardt; Nancy L Haigwood; David Montefiori; Jeffrey D Lifson; Michael P Busch; Christopher J Miller
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.